SGAM
FLXN icon

Smith Group Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Smith Group Asset Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-52,500
Closed -$1.15M – 439
2015
Q2 		$1.15M Buy
52,500
+1,100
+2% +$22.2K 0.04% 166
2015
Q1 		$1.16M Buy
+51,400
New +$1.19M 0.04% 171

Other funds holding FLXN

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Smith Group Asset Management's FLXN Position: Q3 2015 in Review

Smith Group Asset Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2015, closing a stake of 52,500 shares — an estimated $1.15M sold.

Smith Group Asset Management first reported a position in FLXN in Q1 2015 and held it in 2 quarters. The position peaked at $1.16M in Q1 2015. 70 funds tracked by Wall St. Rank hold FLXN as of Q3 2015.

  • Smith Group Asset Management reported no remaining Flexion Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
  • Smith Group Asset Management sold 52,500 Flexion Therapeutics, Inc. shares in Q3 2015, an estimated $1.15M.
  • Smith Group Asset Management first reported a position in Flexion Therapeutics, Inc. in Q1 2015 and held it in 2 quarters.
  • Smith Group Asset Management's Flexion Therapeutics, Inc. position peaked at $1.16M in Q1 2015.
  • 70 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2015.

Based on Smith Group Asset Management's 13F filing for Q3 2015, filed 23 Oct 2015.